Cognate Biolabs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 40.60%
- Profit Growth 72.59%
- Ebitda 71.02%
- Net Worth 112.80%
- Total Assets 86.09%
About Cognate Biolabs
Cognate Biolabs Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 September 2018 (Six years and four months 29 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Mehta and Mrinal Kuri serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73200KA2018PTC116118
-
Company No.
116118
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Sep 2018
-
Date of AGM
13 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Cognate Biolabs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Mehta
|
Director | 06-Sep-2018 | Current |
|
Mrinal Kuri
|
Director | 10-Aug-2021 | Current |
Financial Performance of Cognate Biolabs.
Cognate Biolabs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.6% increase. The company also saw a substantial improvement in profitability, with a 72.59% increase in profit. The company's net worth Soared by an impressive increase of 112.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cognate Biolabs?
Unlock access to Cognate Biolabs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Meera Industries LimitedSanjay Mehta is a mutual person
-
Akkad Mehta & Co LlpSanjay Mehta is a mutual person
-
Neogen Chemicals LimitedSanjay Mehta is a mutual person
-
Span Divergent LimitedSanjay Mehta is a mutual person
-
Neogen Ionics LimitedSanjay Mehta is a mutual person
-
Buli Chemicals India Private Limited
Sanjay Mehta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cognate Biolabs?
Unlock and access historical data on people associated with Cognate Biolabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cognate Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cognate Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
